Association between telomere length and survival in patients with idiopathic pulmonary fibrosis

Respirology

Volumn 20, Issue 6, 2015, Pages 947-952

  Dai, Jinghong ^a   Cai, Hourong ^a   Li, Hui ^a   Zhuang, Yi ^a   Min, Haiyan ^a   Wen, Yanting ^a   Yang, Jie ^a   Gao, Qian ^a   Shi, Yi ^a   Yi, Long ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

age adjusted; idiopathic pulmonary fibrosis; survival; telomerase; telomere length

Indexed keywords

CARBON MONOXIDE;

ADULT; AGE; AGED; ARTICLE; CHROMOSOME SIZE; CONTROLLED STUDY; DEATH; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; GENE MUTATION; HUMAN; HUMAN TISSUE; LEUKOCYTE; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK FACTOR; SEX; SURVIVAL; SURVIVAL TIME; TELOMERE; UNIVERSITY HOSPITAL; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; TELOMERE HOMEOSTASIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; RISK FACTORS; TELOMERE HOMEOSTASIS;

EID: 84936998384     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12566     Document Type: Article

References (22)

1. Gross TJ, Hunninghake GW,. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 2001; 345: 517-525.
2. King TJ, Tooze JA, Schwarz MI, Brown KR, Cherniack RM,. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med. 2001; 164: 1171-1181.
3. Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, Olschewski M, Rottoli P, Muller-Quernheim J,. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 717-723.
4. Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, Shiratori M, Kuroki Y, Abe S,. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 2000; 162: 1109-1114.
5. Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, Li K, Choi J, Vuga LJ, Lindell KO, et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2012; 185: 67-76.
6. Armanios M,. Telomerase and idiopathic pulmonary fibrosis. Mutat. Res. 2012; 730: 52-58.
7. Lawson WE, Loyd JE, Degryse AL,. Genetics in pulmonary fibrosis-familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 2011; 341: 439-443.
8. Armanios M,. Syndromes of telomere shortening. Annu. Rev. Genomics Hum. Genet. 2009; 10: 45-61.
9. Fernandez BA, Fox G, Bhatia R, Sala E, Noble B, Denic N, Fernandez D, Duguid N, Dohey A, Kamel F, et al. A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features. Respir. Res. 2012; 13: 64-74.
10. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JR, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2007; 356: 1317-1326.
11. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD, Vulto I, Xie M, Qi X, Tuder RM, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 13051-13056.
12. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
13. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 2000; 161: 646-664.
14. Dai J, Cai H, Zhuang Y, Wu Y, Min H, Li J, Shi Y, Gao Q, Yi L,. Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population. Respirology 2015; 20: 122-128.
15. Cawthon RM,. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009; 37: e21.
16. Stuart BD, Lee JS, Kozlitina J, Noth I, Devine MS, Glazer CS, Torres F, Kaza V, Girod CE, Jones KD, et al. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir. Med. 2014; 2: 557-565.
17. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho RA,. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392: 569-574.
18. Strong MA, Vidal-Cardenas SL, Karim B, Yu H, Guo N, Greider CW,. Phenotypes in mTERT(+)/(-) and mTERT(-)/(-) mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase. Mol. Cell. Biol. 2011; 31: 2369-2379.
19. Schissel SL, Layne MD,. Telomerase, myofibroblasts, and pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2006; 34: 520-522.
20. Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, Hansell DM, du Bois RM, Wells AU,. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur. Respir. J. 2010; 35: 830-835.
21. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, Rosenblatt RL, Shay JW, Garcia CK,. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl. Acad. Sci. U.S.A. 2007; 104: 7552-7557.
22. Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, Garcia CK,. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 729-737.